Estudos com voluntários saudáveis em Greenville, SC
16 estudos em locais em Greenville e arredores aceitam voluntários saudáveis — pessoas sem a condição estudada. Muitos estudos pagam aos participantes pelo tempo e deslocamento; o valor é definido por cada estudo, então consulte a equipe responsável.
Texto oficial do estudo (Inglês)
Education & Mentorship of Advanced Practice Providers to Increase Community-based Research Within the NCORP Network, COACH-APP Trial
RecrutandoVoluntários saudáveis bem-vindos
- Prisma Health Cancer Institute - Faris, Greenville
- Prisma Health Cancer Institute - Eastside, Greenville
A Clinical Study of Novel Pneumococcal Vaccine V118C in Children (V118C-002)
RecrutandoFase 1Voluntários saudáveis bem-vindos
- Tribe Clinical Research, LLC-Pediatrics ( Site 1008), Greenville
Surgical Thromboprophylaxis Practices in Oncology Patients Within the NCORP Network, STOP-VTE Study
RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos
- Prisma Health Greenville Memorial Hospital, Greenville
Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
RecrutandoVoluntários saudáveis bem-vindos
- Prisma Health Cancer Institute - Butternut, Greenville
- Prisma Health Cancer Institute - Faris, Greenville
- Prisma Health Cancer Institute - Eastside, Greenville
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos
- Prisma Health Cancer Institute - Faris, Greenville
- Prisma Health Greenville Memorial Hospital, Greenville
Buprenorphine Implementation at Syringe Service Programs to Reduce Overdoses
RecrutandoVoluntários saudáveis bem-vindos
- Challenges, Inc/Prisma Health, Greenville
Comparison of Two Different Sperm Processing Methods and Their Effects on Sperm DNA Fragmentation and Embryo Development
RecrutandoVoluntários saudáveis bem-vindos
- Prisma Health-Upstate Fertility Center of the Caroliinas, Greenville
A Phase 3 Study of Revaccination in Subsequent Pregnancies With Bivalent RSV Vaccine and Duration of Protection of a Single Dose
RecrutandoFase 3Voluntários saudáveis bem-vindos
- Prisma Health Maternal Fetal Medicine, Greenville
- Prisma Health OBGYN Center, Greenville
A Study of BLB-201 RSV Vaccine in Infants and Children
RecrutandoFase 1/2Voluntários saudáveis bem-vindos
- Tribe Clinical Research, LLC Parkside Pediatrics Verdae, Greenville
- Tribe Clinical Research, LLC Parkside Pediatrics, Greenville
Comparing Telephone Symptom Monitoring Interventions for Managing Symptoms and Psychological Distress During Oral Anti-Cancer Treatment
RecrutandoVoluntários saudáveis bem-vindos
- Prisma Health Cancer Institute - Butternut, Greenville
- Prisma Health Cancer Institute - Faris, Greenville
- Prisma Health Greenville Memorial Hospital, Greenville
- e mais 1
STEPS: Substance Use Trial of E-cigarettes or Pharmacotherapy for Smoking
RecrutandoVoluntários saudáveis bem-vindos
- Phoenix Center, Greenville
A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease
RecrutandoFase 1/2Voluntários saudáveis bem-vindos
- Local Institution - 0027, Greenville
Robotic Versus Open Ventral Hernia Repair
RecrutandoVoluntários saudáveis bem-vindos
- Prisma Health Greenville Memorial Hospital, Greenville
A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine When Given to Healthy Children 12 to 15 Months of Age
RecrutandoFase 3Voluntários saudáveis bem-vindos
- GSK Investigational Site, Greenville
Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors
RecrutandoFase 3Voluntários saudáveis bem-vindos
- Saint Francis Hospital, Greenville
- Prisma Health Cancer Institute - Butternut, Greenville
- Prisma Health Cancer Institute - Faris, Greenville
- e mais 2
Prevent Cancer- Greenville
RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos
- Prisma Health-Upstate, Greenville
Fonte: ClinicalTrials.gov, dados obtidos em 6 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.